NASDAQ: ATHAAthira Pharma Inc Stock Ownership - Who owns Athira Pharma?
Insider buying vs selling
Have Athira Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kevin Church | CHIEF SCIENTIFIC OFFICER | 2024-09-05 | 2,525 | $0.57 | $1.43kSell |
| Mark James Litton | President and CEO | 2024-09-05 | 5,032 | $0.57 | $2.85kSell |
| Mark Worthington | GENERAL COUNSEL | 2024-09-05 | 2,525 | $0.57 | $1.43kSell |
| Rachel Lenington | COO and CDO | 2024-09-05 | 2,525 | $0.57 | $1.43kSell |
| Andrew Gengos | CFO and Chief Business Officer | 2024-09-05 | 1,272 | $0.57 | $719.95Sell |
| Kelly A. Romano | Director | 2024-06-24 | 27,400 | $2.42 | $66.17kBuy |
| Kelly A. Romano | Director | 2024-06-21 | 15,000 | $2.26 | $33.87kBuy |
| Kevin Church | CHIEF SCIENTIFIC OFFICER | 2024-05-20 | 4,953 | $1.34 | $6.64kBuy |
| Mark Worthington | GENERAL COUNSEL | 2024-05-20 | 10,000 | $1.34 | $13.40kBuy |
| Andrew Gengos | CFO and Chief Business Officer | 2024-05-20 | 10,000 | $1.34 | $13.40kBuy |
ATHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATHA insiders and whales buy or sell their stock.
ATHA Shareholders
What type of owners hold Athira Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 13.97% | 5,402,964 | $3.38M | Insider |
| Perceptive Advisors LLC | 13.97% | 5,402,964 | $3.38M | Institution |
| Joseph Edelman | 8.06% | 3,114,805 | $1.95M | Insider |
| Rtw Investments LP | 6.90% | 2,668,913 | $1.67M | Insider |
| Vanguard Group Inc | 4.17% | 1,613,063 | $1.01M | Institution |
| Simplify Asset Management Inc | 3.86% | 1,492,792 | $933.00k | Institution |
| Propel Bio Management LLC | 3.86% | 1,492,792 | $933.00k | Institution |
| Tang Capital Management LLC | 1.55% | 600,000 | $375.00k | Institution |
| Blackrock Inc 1 | 1.38% | 535,543 | $334.71k | Institution |
| Pathstone Holdings LLC | 1.27% | 492,126 | $307.58k | Institution |
ATHA vs Biotech Stocks
Athira Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.